---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042582"
form_type: "8-K"
ticker: "GCTK"
cik: "0001506983"
company_name: "Glucotrack, Inc."
filed_at: "2026-09-14T20:15:37+00:00"
generated_at: "2026-09-14T20:16:15.091784+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Glucotrack stockholders approve ELOC and bridge note share issuances

## Summary
- Special meeting Sep 11, 2026: quorum 3,661,960 shares (34.61% of 10,578,822 outstanding).
- Proposal 1 (ELOC with White Lion Capital): 3,101,374 for, 228,374 against, 332,212 abstentions — approved.
- Proposal 2 (Bridge Notes/Warrants): 3,106,894 for, 226,850 against, 328,216 abstentions — approved.
- Adjournment proposal not presented because Proposals 1 and 2 passed.
- Sep 14, 2026 amendment to Common Warrants requires stockholder approval before exercise per Nasdaq Listing Rule 5635(d).

## SEC filing metadata
- accession: 0001493152-26-042582
- form_type: 8-K
- ticker: GCTK
- cik: 0001506983
- company_name: Glucotrack, Inc.
- filed_at: 2026-09-14T20:15:37+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506983/000149315226042582/0001493152-26-042582-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506983/000149315226042582/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042582
- JSON: https://secwatch.observer/filing/0001493152-26-042582.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042582.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.